Proinflammatory Cytokines and CD40 Ligand Enhance Cross-Presentation and Cross-Priming Capability of Human Dendritic Cells Internalizing Apoptotic Cancer Cells-Reference-Cited by-同舟云学术

Proinflammatory Cytokines and CD40 Ligand Enhance Cross-Presentation and Cross-Priming Capability of Human Dendritic Cells Internalizing Apoptotic Cancer Cells

Published:2001-03 Issue:2 Volume:24 Page:162-171
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:Journal of Immunotherapy

Author:

Hoffmann Thomas K.,Meidenbauer Norbert,Müller-Berghaus Jan,Storkus Walter J.,Whiteside Theresa L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference40 articles.

1. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

2. A New Era for Cancer Immunotherapy Based on the Genes that Encode Cancer Antigens

3. Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

4. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell–dendritic cell hybrids

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer;BMC Gastroenterology;2022-07-15

2. The human anti-CD40 agonist antibody mitazalimab (ADC-1013; JNJ-64457107) activates antigen-presenting cells, improves expansion of antigen-specific T cells, and enhances anti-tumor efficacy of a model cancer vaccine in vivo;Cancer Immunology, Immunotherapy;2021-05-05

3. Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer;Frontiers in Immunology;2021-03-29

4. Engineering anti-cancer nanovaccine based on antigen cross-presentation;Bioscience Reports;2019-10

5. TNF-receptor superfamily agonists as molecular adjuvants for cancer vaccines;Current Opinion in Immunology;2017-08